MAPS & ITEC Cohorts: 6-8 Years Follow-up

PHASE2CompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

December 5, 2018

Study Completion Date

January 15, 2019

Conditions
ImmunotherapyAllergy and ImmunologyAsthma
Interventions
DRUG

House dust-mite SLIT

received 2000 standard treatment units of glycerinated HDM allergen extract (ALK-AbellÓ) per day. Normal saline was administered to the placebo group. 11 µg of HDM allergen (equal parts of Dermatophagoides pteronyssinus and Dermatophagoides farinae) administered twice daily as oral drops.

DRUG

Normal saline

Normal saline administered in same frequency and manner as intervention

Trial Locations (2)

SO16 6YD

University Hospital Southampton NHS Foundation Trust, Southampton

PO30 5TG

David Hyde Asthma and Allergy Centre, Newport

All Listed Sponsors
collaborator

Isle of Wight NHS Trust

OTHER

lead

University of Southampton

OTHER

NCT03763630 - MAPS & ITEC Cohorts: 6-8 Years Follow-up | Biotech Hunter | Biotech Hunter